MOC Molecure S.A.

1.350USD5.430 PLN · GPW+0.93%Mkt Cap: 33.38M USDP/E: —

Molecure S.A., a biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland. The company is involved in the development of OATD-01, a ch…

Key Statistics

Company
Market Cap33.38M USD
Enterprise Value23.62M USD
Revenue (TTM)1.62M USD
Gross Profit-847.50K USD
Net Income (TTM)-7.78M USD
Revenue/Share0.08 USD
Last Price1.350 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLONCTH00011
Valuation
P/E (Trailing)—
P/E (Forward)-54.30
PEG—
EV/EBITDA-6.08
EV/Revenue14.57
P/S20.59
P/B1.25
EPS (TTM)-0.25 USD
EPS (Forward)—
52W Range
1.23811% of range2.247
52W High2.247 USD
52W Low1.238 USD
Profitability
Gross Margin-253.98%
Oper. Margin-253.98%
EBITDA Margin-239.77%
Profit Margin-240.64%
ROE-30.26%
ROA-27.51%
ROIC-34.94%
ROCE-29.74%
Growth
Revenue Growth29.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.17M USD
CapEx (TTM)5.91M USD
FCF Margin—
FCF Yield—
Net Debt-4.20M USD
Net Debt/EBITDA1.08
Net Debt/FCF—
Balance Sheet
Debt/Equity0.07
Current Ratio—
Quick Ratio—
Book Value/Sh1.08 USD
Cash/Share0.27 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.182 USD
Upside (mean)+135.7%
Target Range2.635 USD – 3.729 USD
2.635+135.7% to mean3.729
# Analysts2
Ownership
Shares Out.24.72M
Float13.29M
Insiders29.29%
Institutions9.31%
Technical
SMA 501.609 (-16.1%)
SMA 2001.527 (-11.6%)
Beta1.02
S&P 52W Chg12.00%
Avg Vol (30d)43.56K
Avg Vol (10d)41.58K
Technical Indicators
RSI (14)37.8
MACD-0.2044
MACD Signal-0.1298
MACD Hist.-0.0746
BB Upper1.796 USD
BB Middle1.491 USD
BB Lower1.186 USD
BB Width40.96%
ATR (14)0.0891 USD
Vol Ratio (20d)0.83x

About Molecure (WSE: MOC)

›

Molecure (WSE: MOC) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 5.430 PLN on 19 November 2026, down 35.5% over 52 weeks. Its 52-week range is 4.980 PLN to 9.040 PLN: the price is 39.9% below the high and 9.0% above the low.

Its market capitalisation is 134.25M PLN.

Molecure reports return on equity of -30.3%, an operating margin of -254.0% and revenue up 29.0% year over year.

It holds more cash than debt, a net cash position of 16.88M PLN. Its Piotroski F-score is 0 out of 9, a weak reading of its financial health. 2 analysts cover the stock; their mean price target of 12.80 PLN is 135.7% above the current price.